Molecular Chaperones in Cancer and Protein Quality Control Frontiers in Immunomodulation and Cancer Therapy (2nd edition)

Inicio | Eventos | Targeting strategies for the development of highly selective allosteric and orthosteric kinase inhibitors

Targeting strategies for the development of highly selective allosteric and orthosteric kinase inhibitors

Información

Fecha: 01/12/2023
Hora 12:00
Lugar: Auditorio CNIO
Conferenciante Stefan Knapp
Procedencia Goethe University Frankfurt (SGC Frankfurt), Germany
Invitado por Ivan Plaza, Protein Phosphorylation and Cancer Group, Structural Biology Programme
Entrada libre hasta completar aforo

Subir